Cognis in brief
Company portrait
Cognis is a leading supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 5,500 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for the pharma, foods, beverages and dietary supplements markets, as well as for the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, agriculture and mining.
Cognis is owned by private equity funds advised by Permira, GS Capital Partners and SV Life Sciences. In 2009, Cognis recorded sales of about 2,6 billion euros and an Adjusted EBITDA (operating result) of 364 million euros.
Product portfolio and markets
Cognis' three strategic business units (SBUs) are aligned with the markets of our customers' customers. All three SBUs develop innovative solutions for the respective markets using a large share of natural, renewable raw materials and the expertise in specialty chemicals especially in surfactant and surface technology. At the same time, all three SBUs complement each other through in-depth knowledge of the relevant consumer markets.
Company structure
| Headquarters |
Monheim, Germany |
| Fields of business |
Specialty chemicals and nutritional ingredients, with focus on the areas of wellness and sustainability
- Care Chemicals: Products and solutions for the personal and
home care industry
- Nutrition & Health: Products and solutions for the healthcare and
food market
- Functional Products: Products and solutions for industrial markets such as coatings and inks, lubricants, crop protection and mining.
|
Production sites and offices |
62 locations in 30 countries |
| Employees worldwide |
approximately 5,500 |
| Management Board |
- Dr. Antonio Trius, Chief Executive Officer (CEO)
- Paul Allen, Executive Vice President Functional Products
- Stephane Baseden, Executive Vice President Nutrition & Health
- Dr. Helmut Heymann, Chief Administration Officer (CAO)
- Dr. Marco Panichi, Chief Financial Officer (CFO)
- Richard Ridinger, Executive Vice President Care Chemicals
|
Shareholders since November 30, 2001 |
Permira Funds GS Capital Partners SV Life Sciences |
Sales by strategic business units 2009
| Total |
€ 2,584 million |
| Care Chemicals |
€ 1,457 million |
| Nutrition & Health |
€ 325 million |
| Functional Products |
€ 786 million |
| Other Activities |
€ 16 million |
| Adjusted EBITDA 2009 |
€ 364 million |
Cognis in Brief 2010
English version (2.5 MB pdf)
German version (2.0 MB pdf)